Wakamoto Pharmaceutical Co., Ltd.

VSY Biotechnology's Sinusoidal Trifocal IOL Technology Receives Japanese Approval

- VSY Biotechnology GmbH's Sinusoidal Trifocal Technology® has received official approval in Japan, marking the company's entry into the Japanese ophthalmic market. - The innovative IOL technology eliminates traditional challenges of light loss, light scatter, and poor night vision associated with sawtooth technology used in conventional trifocal lenses. - WAKAMOTO PHARMACEUTICAL CO., LTD will serve as the official distributor in Japan, with non-toric lenses already launching in the market. - The technology provides superior visual performance across near, intermediate, and distance ranges while reducing side effects such as halos and glare.